Triamcinolone Offers Relief in Thyroid Eye Disease

by Medscape • 2024/05/29 • 0 Comments

Percutaneous injection of triamcinolone improved margin reflex distance 1 and upper eyelid retraction in patients with thyroid eye disease.
Medscape Medical News

← Bausch + Lomb receives Canadian approval for enVista Envy IOL

Resumen: Nordic Group B.V., a través de su filial Nordic Pharma, Inc. (EE. UU.), anuncia el lanzamiento del gel canalicular LACRIFILL®, una nueva terapia para el síndrome del ojo seco. →

Post navigation